ArticleOncotarget2016

Crosstalk between the IGF-1R/AKT/mTORC1 pathway and the tumor suppressors p53 and p27 determines cisplatin sensitivity and limits the effectiveness of an IGF-1R pathway inhibitor.

Batzaya Davaadelger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.